Healthcare and pharmaceuticals team - two new appointments

Healthcare and pharmaceuticals team - two new appointments

Royal Bank of Scotland Corporate & Institutional Banking (RBS CIB) is growing its market-leading healthcare and pharmaceuticals team with the appointments of Emily Makinson and Paul Weeks as associate director and director respectively.

Our news

07 January 2013

The appointments are part of RBS CIB’s drive to enhance the range of services it offers to clients in the healthcare sector. Makinson and Weeks will work to build the team’s proposition into the fast-growing medical technology (‘medtech’) and pharmaceutical industries, whilst also continuing to focus on corporates in the private care and hospital spaces.

Makinson moves to her new position from RBS’s Structured Finance Corporates team where she played a lead role in the recent financings for Abbey Total Care Group and of Grant Thornton UK LLP. Prior to this she has spent time in RBS’s Markets and International Banking (M and IB) Loan Market Origination team, having joined Royal Bank of Scotland in 2008 on its Corporate Banking Graduate Programme.

Weeks joins the healthcare and pharmaceuticals team from RBS’s Global Restructuring Group. As corporate relationship director, his role was to pursue turnaround opportunities for financially distressed corporates, focusing on operational and balance sheet restructures. Paul started his career as a graduate trainee at RBS Insurance and has since worked as strategy manager for RBS Major Corporate Banking and assistant director for RBS Property Structured Finance.

Based at the bank’s Bishopsgate offices in London, RBS CIB’s healthcare and pharmaceuticals team works with a wide range of organisations from care homes and dental practices to suppliers of medical devices. It helps them with a variety of financing requirements including the provision of world-class day-to-day operational banking through to funding growth via acquisition and capital expansion.

"I am absolutely delighted to be joining the healthcare and pharmaceuticals team. It is a fast growing and dynamic part of RBS and, capitalising on the team’s already strong presence in the market, we have exciting expansion plans for the division. I look forward to working with my new colleagues and clients to grow the business."

Paul Weeks

"The healthcare and pharmaceuticals team already has an impressive track record, counting Nuffield Hospitals and the Priory Group among its clients. This is an exciting time for the division, and our expansion of the business into the pharmaceutical and medtech sectors further underlines our commitment to companies within the healthcare industry."

Emily Makinson

Posted In

Our news


Latest news

Women and millennials help drive £17bn+ franchise sector to record levels

New research from NatWest and the British Franchise Association (bfa) highlights changes and profitability in the sector.

Winners announced for Skills & Opportunities Fund

52 winning organisations have been announced for round two of the 2018 Skills & Opportunities Fund.

RBS Multicultural Network meets Eric Holder, 82nd US Attorney General

Simon McNamara, RBS Chief Administrative Officer and Executive Sponsor of the RBS Multicultural Network, recently hosted an event in discussion with Eric Holder, the first black US Attorney General. They discussed career, ethnicity, diversity and even a little bit of politics. At the event, Eric Holder shared his wisdom and experience with attendees from the RBS Executive committee and RBS Multicultural Network. Simon McNamara blogs about his experience meeting Eric, a BAME role model, and why diversity is so important to RBS.

Set Tab for lightbox